Amit Anand, MD

Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Publications

  • Published 2/23/2025

    Sanacora G, Barnett BS, Hu B, Goes FS, Mathew SJ, Murrough JW, Reti I, Wilkinson ST, Anand A. Patient preference effects in a randomized comparative effectiveness study of electroconvulsive therapy and ketamine for treatment resistant depression: An ELEKT-D trial secondary analysis. Psychiatry Res. 2025 May; 347:116411. PMID: 40049091.

    Read at: PubMed

  • Published 12/12/2024

    Reilly-Harrington NA, Falcone T, Jobes DA, Deisz C, Flannery C, Wolf A, Hu B, Anand A. Ketamine treatment in youth for fast reduction of suicidality and engagement in psychotherapy: A randomized placebo-controlled trial protocol. Contemp Clin Trials. 2025 Feb; 149:107777. PMID: 39672260.

    Read at: PubMed

  • Published 6/3/2024

    Jha MK, Wilkinson ST, Krishnan K, Collins KA, Sanacora G, Murrough J, Goes F, Altinay M, Aloysi A, Asghar-Ali A, Barnett B, Chang L, Costi S, Malone D, Nikayin S, Nissen SE, Ostroff R, Reti I, Wolski K, Wang D, Hu B, Mathew SJ, Anand A. Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2024 Jun 03; 7(6):e2417786. PMID: 38916891.

    Read at: PubMed

  • Published 12/1/2023

    Mathew SJ, Jha MK, Anand A. Choosing Between Ketamine and Electroconvulsive Therapy for Outpatients With Treatment-Resistant Depression-Advantage Ketamine? JAMA Psychiatry. 2023 Dec 01; 80(12):1187-1188. PMID: 37878334.

    Read at: PubMed

  • Published 9/7/2023

    Anand A, Mathew SJ, Hu B. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. Reply. N Engl J Med. 2023 Sep 07; 389(10):961-962. PMID: 37672705.

    Read at: PubMed

Websites

Education

  • Seth G.S. Medical College, MBBS